FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...
Publications
View AllTrastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Among patients with HER2-positive early breast cancer who had residual invasive disease after completion of neoadjuvant therapy, the risk of recurrence of invasive breast cancer...
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
In this trial involving patients with HER2-low metastatic breast cancer, trastuzumab deruxtecan resulted in significantly longer progression-free and overall survival than the p...
Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing
Reepithelialization during cutaneous wound healing involves numerous signals that result in basal keratinocyte activation, spreading, and migration, all linked to a loosening of...
Affiliated Researchers
Institution Info
- Type
- facility
- Country
- FR
- Publications
- 5
- Citations
- 9,046
External Links
Identifiers
- ROR
- https://ror.org/03capj968